Source: Molecular Pharmaceutics. Unidades: FMRP, FFCLRP
Subjects: ÓXIDO NÍTRICO, RUTÊNIO, NANOPARTÍCULAS, MICROSCOPIA ELETRÔNICA DE VARREDURA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Anderson J. e ESPREAFICO, Enilza Maria e TFOUNI, Elia. Trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16–F10 cells: cytotoxicity and phototoxicity. Molecular Pharmaceutics, v. 10, n. 10, p. 3544-3554, 2013Tradução . . Disponível em: https://doi.org/10.1021/mp3005534. Acesso em: 28 set. 2024.APA
Gomes, A. J., Espreafico, E. M., & Tfouni, E. (2013). Trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16–F10 cells: cytotoxicity and phototoxicity. Molecular Pharmaceutics, 10( 10), 3544-3554. doi:10.1021/mp3005534NLM
Gomes AJ, Espreafico EM, Tfouni E. Trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16–F10 cells: cytotoxicity and phototoxicity [Internet]. Molecular Pharmaceutics. 2013 ; 10( 10): 3544-3554.[citado 2024 set. 28 ] Available from: https://doi.org/10.1021/mp3005534Vancouver
Gomes AJ, Espreafico EM, Tfouni E. Trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16–F10 cells: cytotoxicity and phototoxicity [Internet]. Molecular Pharmaceutics. 2013 ; 10( 10): 3544-3554.[citado 2024 set. 28 ] Available from: https://doi.org/10.1021/mp3005534
